Search

Alvin Katz Phones & Addresses

  • Boca Raton, FL
  • 16421 Maddalena Pl, Delray Beach, FL 33446 (561) 498-0542
  • Port Washington, NY
  • 201 Parkway Dr, Roslyn Heights, NY 11577 (516) 621-0668 (516) 621-6647
  • 553 Dune Rd, Westhampton Beach, NY 11978 (631) 288-3704
  • Roslyn Hts, NY
  • Brooklyn, NY
  • 2600 S Ocean Blvd APT 11B, Boca Raton, FL 33432

Work

Company: Alvin Katz MD Address: 200 Grand Ave Suite 204, Englewood, NJ 07631 Phones: (201) 816-0600

Education

School / High School: SUNY Downstate Medical Center College Of Medicine 1963

Languages

English • Arabic • Spanish

Awards

Healthgrades Honor Roll

Ranks

Certificate: Otolaryngology, 1971

Specialities

Ear, Nose, and Throat

Professional Records

Medicine Doctors

Alvin Katz Photo 1

Dr. Alvin Katz, Englewood NJ - MD (Doctor of Medicine)

View page
Specialties:
Ear, Nose, and Throat
Address:
Alvin Katz MD
200 Grand Ave Suite 204, Englewood, NJ 07631
(201) 816-0600 (Phone)

Alvin Katz MD
45 E 72Nd St, New York, NY 10021
(212) 879-3292 (Phone)
Certifications:
Otolaryngology, 1971
Awards:
Healthgrades Honor Roll
Languages:
English
Arabic
Spanish
Hospitals:
Alvin Katz MD
200 Grand Ave Suite 204, Englewood, NJ 07631

Alvin Katz MD
45 E 72Nd St, New York, NY 10021

Lenox Hill Hospital
100 East 77Th Street, New York, NY 10075

Long Island Jewish Medical Center
270 05 76Th Avenue, New Hyde Park, NY 11040

NewYork-Presbyterian/Weill Cornell Medical Center
525 East 68Th Street, New York, NY 10065
Education:
Medical School
SUNY Downstate Medical Center College Of Medicine
Graduated: 1963
Medical School
Kings County Hospital Center
Graduated: 1964
Medical School
Manhattan Ee Throat Hospital
Graduated: 1968
Medical School
Nyu Bellevue
Graduated: 1965
Alvin Katz Photo 2

Alvin Katz

View page
Specialties:
Otolaryngology
Work:
Alvin Katz MD
45 E 72 St APT 1A, New York, NY 10021
(212) 879-3292 (phone), (212) 988-2507 (fax)

Alvin Katz MD
200 Grand Ave STE 204, Englewood, NJ 07631
(201) 816-0600 (phone), (201) 816-0900 (fax)
Education:
Medical School
SUNY Downstate Medical Center College of Medicine
Graduated: 1963
Conditions:
Acute Pharyngitis
Labyrinthitis
Acute Sinusitis
Allergic Rhinitis
Chronic Sinusitis
Languages:
Arabic
English
Description:
Dr. Katz graduated from the SUNY Downstate Medical Center College of Medicine in 1963. He works in Englewood, NJ and 1 other location and specializes in Otolaryngology. Dr. Katz is affiliated with Lenox Hill Hospital.

Business Records

Name / Title
Company / Classification
Phones & Addresses
Alvin Katz
Medical Doctor, Otolaryngology, Principal
Alvin Katz MD
Medical Doctor's Office
200 Grand Ave, Englewood, NJ 07631
Alvin Katz
Sales And Marketing Executive
Goldstein, Alvin P MD PC
Medical Doctor's Office
949 Central Ave, Woodsburgh, NY 11598
109 Woodmere Blvd S, Woodsburgh, NY 11598
(516) 374-5550
Alvin Katz
Chairman, Secretary, Treasurer
AQUA CORP
2600 S Ocean Blvd Lph 21 A, Boca Raton, FL 33432
4001 N Ocean Blvd, Boca Raton, FL 33431
4B 4001 N Ocean Blvd, Boca Raton, FL 33431
2600 S Ocean Blvd, Boca Raton, FL 33432
Alvin Katz
AARON K. STABLE, INC
201 Pkwy Dr, Roslyn Heights, NY 11577
Alvin Katz
STERLING SALES, LTD
380 N Broadway, Jericho, NY 11753
34 Alorn, Plainview, NY 11803
Alvin Katz
President, Director
BIRCH POINTE CONDOMINIUM ASSOCIATION, INC
301 N Birch Rd, Fort Lauderdale, FL 33304
Alvin S. Katz
Dentist, Family And General Dentistry
Dental Health Services PC
Dentist's Office
146 Newbridge Rd, Hicksville, NY 11801
PO Box 912, Bethpage, NY 11714
(516) 931-4500
Alvin Katz
Branch Manager
CGS INDUSTRIES, INC
Whol Women's/Child's Clothing Whol Men's/Boy's Clothing · Whol Men's/Boy's Clothing Whol Women's/Child's Clothing
8-10 W 36 St, New York, NY 10018
8-10 W 36 St 5 Flr, New York, NY 10018
3409 Queens Blvd, Long Island City, NY 11101
8 W 36 St, New York, NY 10018
(718) 482-0700

Publications

Isbn (Books And Publications)

Optical Biopsy VI: 24 January 2006, San Jose, California, USA

View page
Author

Alvin Katz

ISBN #

0819461334

Us Patents

Phosphorescence And Fluorescence Spectroscopy For Detection Of Cancer And Pre-Cancer From Normal/Benign Regions

View page
US Patent:
7986989, Jul 26, 2011
Filed:
Sep 14, 2006
Appl. No.:
11/521170
Inventors:
Robert R. Alfano - Bronx NY, US
Aleksandra Alimova - Bronx NY, US
Alvin Katz - Bronx NY, US
Assignee:
The Research Foundation of the City University of New York - New York NY
International Classification:
A61B 6/00
G01N 21/64
G01N 21/76
US Classification:
600476, 600477, 422 8208, 436172
Abstract:
The present application is directed to methods for detecting cancerous, pre-cancerous and benign/normal tissue using phosphorescence or the combination of fluorescence and phosphorescence emission from the tissue excited in 280 to 340 nm range. In particular, the application describes methods using a ratio of intensity of fluorescence emission to intensity of phosphorescence emission to provide a rapid cancer, pre-cancer and benign detection method. Normal human breast and prostate tissue, excited in 270 to 300 nm range, express the emission signatures at 340 nm, 440 nm and 500 nm. Cancerous tissue shows only minor emissions at 500 nm, thus the ratio of 340 nm peak to 500 nm peak emission intensities provides information about malignancy of a tissue. Fiber optic based instrumentation can be used to collect the luminescence signal from an area of a tissue less than 1 mm in diameter and using the described method can be screened to determine the state of the tissue sample taken. The combination of fiber optics and 2D translation stage provides 2D maps of intensity's ratio of the tissue surface and aids in localizing the malignancy region of the tissue.

Micro-Scale Compact Device For In Vivo Medical Diagnosis Combining Optical Imaging And Point Fluorescence Spectroscopy

View page
US Patent:
8082024, Dec 20, 2011
Filed:
Jan 18, 2005
Appl. No.:
11/037961
Inventors:
Robert R. Alfano - Bronx NY, US
Alvin Katz - Bronx NY, US
Scott Alfano - Bronx NY, US
International Classification:
A61B 6/00
US Classification:
600476, 600473
Abstract:
An apparatus and method for medical practitioners to detect the presence of abnormal cells including cancerous and pre-cancerous cells by using a transport capsule containing an imaging apparatus including UV sources and fluorescence detectors for obtaining images and fluorescence data of biological cells and tissue. The method includes the steps of scanning biological tissue using an ultra-violet (UV) source to obtain fluorescence data, transferring fluorescence data and/or images using a radio frequency (RF) or other suitable means to a personal computer (PC) system, analyzing the image and/or fluorescence data in the PC, identifying -tissues with precancerous and cancerous cells, and optionally determining their precise location, and assessing the accuracy of the calculated fluoroscopic images.

Method And System For Detection By Raman Measurements Of Bimolecular Markers In The Vitreous Humor

View page
US Patent:
20020095257, Jul 18, 2002
Filed:
Mar 26, 2001
Appl. No.:
09/817760
Inventors:
Richard Rosen - New York NY, US
Erik Kruger - Cambridge MA, US
Alvin Katz - Bronx NY, US
Robert Alfano - Bronx NY, US
International Classification:
G06F019/00
G01N033/48
G01N033/50
A61B003/10
US Classification:
702/019000, 351/205000
Abstract:
A system to detect eye disease in which monochromatic laser light is directed into the vitreous humor after passing through the front of the eye. A very sensitive detection system then detects the light scattered from the vitreous humor as it exits the eye. The light is scattered at a wavelength different from that of the laser in a manner known as Raman scattering. The wavelength of the Raman scattered photons are shifted by vibrational modes of the molecules, and this shift is a characteristic feature of the molecules interacting with the light. In this way, the Raman scattered light is essentially imprinted with a fingerprint of relevant molecules. As it exits the eye, this Raman scattered light can be separated from other types of scattered light and then routed to a detection system, wherein the results are calibrated against actual standards for the particular vitreous substances being analyzed. An optic arrangement tightly focuses the laser into the vitreous humor and thereby reduces the spectral fingerprints or noise from proteins and other molecules normally present in the lens, cornea, retina and other eye components.

System And Methods For Laser Treatment Of Ocular Tissue

View page
US Patent:
20040176752, Sep 9, 2004
Filed:
Mar 6, 2003
Appl. No.:
10/383124
Inventors:
Robert Alfano - Bronx NY, US
Tapan Gayen - Brooklyn NY, US
Steven McCormick - New York NY, US
Richard Rosen - New York NY, US
Alvin Katz - Bronx NY, US
Howard Savage - Ossining NY, US
International Classification:
A61B018/20
US Classification:
606/004000, 606/008000
Abstract:
A system and method for exposing ocular tissue to a beam of electromagnetic radiation tuned to an NIR wavelength between about 1380 nm and about 1600 nm in the water absorption band. The laser energy is absorbed by the water, which in turn, transfers the energy to collagen molecules. The helical collagen molecules partially denature and then re-nature to form a weld across the region of the tissues to be joined. In a preferred embodiment, the electromagnetic radiation originates from a laser. The lasers may be Cr doped crystals, Erbium fibers, and alloys of semiconductor laser diodes.

Method For Detecting Cancerous Tissue Using Optical Spectroscopy And Fourier Analysis

View page
US Patent:
57690812, Jun 23, 1998
Filed:
Mar 18, 1996
Appl. No.:
8/618459
Inventors:
Robert R. Alfano - Bronx NY
Alvin Katz - Bronx NY
Yuanlong Yang - New York NY
Assignee:
The Research Foundation of City College of New York - New York NY
International Classification:
A61B 600
US Classification:
128665
Abstract:
A method for detecting cancerous tissue using optical spectroscopy and Fourier analysis. According to a preferred embodiment, a tissue sample is illuminated with light at a wavelength of approximately 300 nm. Next, a fluorescence emission spectrum for the tissue sample is obtained by measuring the resultant fluorescence from the tissue sample over the spectral region from approximately 320 nm to approximately 580 nm. The phase and amplitude for the first three Fourier transform harmonics are then determined. The phase and amplitude determinations for one or more of the three harmonics are then compared to appropriate standards obtained from cancerous and non-cancerous tissue samples. The accuracy of the method can be improved further by comparing the phase and amplitude calculations for at least two harmonics.

Detection Of Cancer And Precancerous Conditions In Tissues And/Or Cells Using Native Fluorescence Excitation Spectroscopy

View page
US Patent:
6091985, Jul 18, 2000
Filed:
Jan 23, 1998
Appl. No.:
9/012482
Inventors:
Robert R. Alfano - Bronx NY
Singaravelu Ganesan - Edison NJ
Alvin Katz - Bronx NY
Assignee:
Research Foundation of City College of New York - New York NY
International Classification:
A61B 500
US Classification:
600476
Abstract:
A method of detecting cancer or precancerous conditions in a tissue or cell using fluorescence excitation spectroscopy. According to one embodiment of the method, a tissue is tested for cancer or a precancerous condition by exciting the tissue with substantially monochromatic light at 268 nm and then at 289 nm, with the resultant native fluorescence emitted from the tissue following each excitation being measured. A ratio of the fluorescence intensities, e. g. , I. sub. 289 /I. sub. 268, is then calculated. If I. sub. 289 /I. sub. 268 is greater than 1. 5, the tissue is cancerous or precancerous whereas if I. sub. 289 /I. sub. 268 is less than 1. 5, the tissue is not cancerous or precancerous.
Alvin A Katz from Boca Raton, FLDeceased Get Report